Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 10, 2020GeroScienceOpen Access

Effect of rapamycin on aging and age-related diseases—past and future

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRamasamy SelvaraniSMSabira MohammedARArlan Richardson

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Selvarani et al. (2020) studied this question.

synapsesocial.com/papers/690cc380f4bc50595eec8fcehttps://doi.org/10.1007/s11357-020-00274-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast1991 · 2,041 citations
  2. 2RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.1994 · 484 citations
  3. 3Longevity, aging and rapamycin2014 · 178 citations
  4. 4How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story2014 · 124 citations
  5. 5Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island2016 · 240 citations